These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7510612)

  • 21. [Prevention and therapy of HIV-infection, current status and perspectives].
    Von Baehr R; Pas P
    Z Arztl Fortbild (Jena); 1990; 84(18):935-41. PubMed ID: 2267828
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological survey for type D retroviruses and simian immunodeficiency virus in monkeys living in Hungary.
    Gyuris A; Vajda G; Földes I
    Acta Vet Hung; 1993; 41(1-2):171-7. PubMed ID: 8116496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccination for HIV-1 and SIV.
    Barouch DH; Letvin NL
    Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus.
    Cranage MP; Polyanskaya N; McBride B; Cook N; Ashworth LA; Dennis M; Baskerville A; Greenaway PJ; Corcoran T; Kitchin P
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):13-22. PubMed ID: 8427714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS 1995. Vaccines and immunology: overview.
    Montelaro RC; Wigzell H
    AIDS; 1995; 9 Suppl A():S111-2. PubMed ID: 8819577
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 28. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
    Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects for a human immunodeficiency virus/AIDS vaccine.
    Murphy FA; Folks TM; Lairmore MD
    Dev Biol Stand; 1990; 72():3-15. PubMed ID: 1704324
    [No Abstract]   [Full Text] [Related]  

  • 30. The relevance of feline retroviruses to the development of vaccines against HIV.
    Jarrett O
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):385-7. PubMed ID: 8882315
    [No Abstract]   [Full Text] [Related]  

  • 31. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current world literature.
    Curr Opin HIV AIDS; 2012 Jan; 7(1):86-95. PubMed ID: 22156801
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization.
    Biberfield G; Putkonen P; Thorstensson R; Norrby E
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies.
    O'Connor DH; Allen TM; Watkins DI
    DNA Cell Biol; 2002 Sep; 21(9):659-64. PubMed ID: 12396608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical microbicides become topical.
    Moore JP
    N Engl J Med; 2005 Jan; 352(3):298-300. PubMed ID: 15659734
    [No Abstract]   [Full Text] [Related]  

  • 38. Animal models for the evaluation of drugs and vaccines for HIV infection and AIDS: report of a WHO Working Group.
    Esparza J
    Dev Biol Stand; 1990; 72():367-72. PubMed ID: 2282993
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicine. Microbicide shuts the door on HIV.
    Cohen J
    Science; 2004 Oct; 306(5695):387. PubMed ID: 15486260
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
    Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.